-
Signature
-
/s/ John S. Hess, Jr. under Power of Attorney
-
Issuer symbol
-
UTHR
-
Transactions as of
-
07 Aug 2025
-
Net transactions value
-
-$1,810,361
-
Form type
-
4
-
Filing time
-
08 Aug 2025, 16:31:01 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| MAHON PAUL A |
EVP & GENERAL COUNSEL |
C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING |
/s/ John S. Hess, Jr. under Power of Attorney |
08 Aug 2025 |
0001231589 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
UTHR |
Common Stock |
Options Exercise |
$1,489,620 |
+11,000 |
+30% |
$135.42 |
47,781 |
07 Aug 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
$413,812 |
-1,391 |
-2.9% |
$297.49 |
46,390 |
07 Aug 2025 |
Direct |
F1, F2 |
| transaction |
UTHR |
Common Stock |
Sale |
$404,179 |
-1,353 |
-2.9% |
$298.73 |
45,037 |
07 Aug 2025 |
Direct |
F1, F3 |
| transaction |
UTHR |
Common Stock |
Sale |
$873,889 |
-2,918 |
-6.5% |
$299.48 |
42,119 |
07 Aug 2025 |
Direct |
F1, F4 |
| transaction |
UTHR |
Common Stock |
Sale |
$852,424 |
-2,837 |
-6.7% |
$300.47 |
39,282 |
07 Aug 2025 |
Direct |
F1, F5 |
| transaction |
UTHR |
Common Stock |
Sale |
$422,634 |
-1,401 |
-3.6% |
$301.67 |
37,881 |
07 Aug 2025 |
Direct |
F1, F6 |
| transaction |
UTHR |
Common Stock |
Sale |
$302,696 |
-1,000 |
-2.6% |
$302.70 |
36,881 |
07 Aug 2025 |
Direct |
F1, F7 |
| transaction |
UTHR |
Common Stock |
Sale |
$30,345 |
-100 |
-0.27% |
$303.45 |
36,781 |
07 Aug 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
UTHR |
Stock Option |
Options Exercise |
$0 |
-11,000 |
-11% |
$0.000000 |
88,000 |
07 Aug 2025 |
Common Stock |
11,000 |
$135.42 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: